S. Shekarriz

Health‐Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

E. Tokunaga, M. Goetz, S. Johnston, 2020, The oncologist.

Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

P. Neven, G. Sledge, E. Grischke, 2020, The oncologist.

Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy

P. Neven, G. Sledge, E. Grischke, 2019, The oncologist.

Comparison of conservative versus surgical therapy for acute appendicitis with abscess in five German hospitals

T. Keck, T. Strate, P. Kujath, 2019, International Journal of Colorectal Disease.